Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Silo Pharma Inc
(OP:
SILO
)
N/A
UNCHANGED
Last Price
Updated: 3:23 PM EDT, Sep 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Silo Pharma Inc
< Previous
1
2
3
Next >
FDA Expands Access to MDMA for Treatment of PTSD
May 18, 2022
Via
Investor Brand Network
Exposures
Product Safety
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) CEO Featured in Bell2Bell Podcast Episode
May 18, 2022
Via
Investor Brand Network
First Psychedelic Trial Clinic Set to Launch in London
May 17, 2022
Via
Investor Brand Network
Researchers Have Found Brain Cells That Die Due to Parkinson’s Disease
May 13, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Spotlight: Ketamine
May 12, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Spotlight: Ketamine
May 11, 2022
Via
Investor Brand Network
Study Finds Service Dogs Help Individuals with PTSD
May 10, 2022
Via
Investor Brand Network
3 Psychedelic Documentaries You Can Watch on YouTube
May 09, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO), Frontage Laboratories to Collaborate in Pharmacokinetic Study
May 06, 2022
Via
Investor Brand Network
New Study Sheds Light on Inflammation Linked to COVID-19
May 05, 2022
Via
Investor Brand Network
Exposures
COVID-19
Studies Find Link Between ADHD, Fibromyalgia
May 04, 2022
Via
Investor Brand Network
Research Highlights the High Economic Cost of PTSD
April 29, 2022
Via
Investor Brand Network
Advocates Urge Use of Alternative Treatments to Curb Veteran Suicides
April 28, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Focusing on Largely Underserved Indications
April 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Study Evalutes Possible Link Between Parkinson’s Disease, Autoimmune Malfunction
April 27, 2022
Via
Investor Brand Network
Study Finds That Psychedelics Free Up Brains of Individuals with Depression
April 26, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Advances with Pharmacokinetic Study – but What is Pharmacokinetics?
April 26, 2022
Via
Investor Brand Network
Scientists Stop Memory Decay by Administering Nasal Therapy to Mice
April 22, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Produces First Batch of SPU-21 Liposomes for RA Study
April 20, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’
April 11, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Why Silo Pharma Inc. (SILO) Is ‘One to Watch’
April 07, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’
March 31, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork
March 30, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Is ‘One to Watch’
March 30, 2022
Via
Investor Brand Network
Why the North America Psychedelic Drugs Market is Expected to Grow With the Fastest CAGR for Next Several Years
June 08, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Why Companies Are Betting Big On Psychedelic Drugs To Treat Mental Health Epidemic
April 28, 2021
Via
FinancialNewsMedia
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted
April 22, 2021
Via
FinancialNewsMedia
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.